“Ending Dementia Stigma could Change its Trajectory: Cancer’s History Shows Why” highlights the impact of cancer advocates from the perspective of the slow progress in the world of dementia research. This article by Saskia Sivananthan recently appeared in The Conversation. “Cancer did not change its stigma entirely because it became curable. It became curable faster because stigma was specifically being addressed and advocacy co-ordinated to push for funding and system change.”
Cancer Research UK (CRUK) has prepared a toolkit to assist researchers in patient and public involvement (PPI), noting that PPI can improve the quality and relevance of the research, and help articulate its benefits for cancer patients and members of the public.
This is an excellent summary of many of the top cancer stories of 2025 from the staff at Cancer Today.
A recent article in MedPage Today discussed the effectiveness of crowdfunding campaigns in meeting the out-of-pocket costs of cancer patients. While well-intentioned, the campaigns raised less than 5% of the out of pocket costs. “Our findings have clinical implications,” the authors wrote. “Discussions of expected cancer treatment costs with the oncology care team have long…
Luisa Fioretto, MD “As a medical student, I believed my role was to cure disease. However, after graduation, I found myself meeting people with all their burden of emotional and psychological complexity. While I was listening to them, I quickly realized that I was becoming part of their journey. In oncology, this became a personal encounter between…
Being a patient research advocate was never something Brittany Lee imagined for herself. After two cancer diagnoses, a debilitating muscle disease, and the loss of close friends, she discovered that advocacy was not only a way to process her own experience but also a way to change the future for others. More